Literature DB >> 14670892

Rethinking prescribing in the United States.

Andrew Ellner1.   

Abstract

Mesh：

Year:  2003        PMID： 14670892      PMCID： PMC293000          DOI： 10.1136/bmj.327.7428.1397

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Pharmacoeconomic analyses: making them transparent, making them credible.

Authors:  D Rennie; H S Luft
Journal:  JAMA       Date:  2000-04-26       Impact factor: 56.272

2.  Direct-to-consumer advertising--strengthening our health care system.

Authors:  Alan F Holmer
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

3.  Promotion of prescription drugs to consumers.

Authors:  Meredith B Rosenthal; Ernst R Berndt; Julie M Donohue; Richard G Frank; Arnold M Epstein
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  The prescription-drug problem.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

5.  Pharmacy benefit managers: a model for Medicare?

Authors:  V V Goff
Journal:  Issue Brief Natl Health Policy Forum       Date:  2001-07-09

Review 6.  Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes.

Authors:  Lisa L Ioannides-Demos; Joseph E Ibrahim; John J McNeil
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  HMO formularies and care costs.

Authors:  S D Horn
Journal:  Lancet       Date:  1996-08-31       Impact factor: 79.321

8.  HMO formularies and care costs.

Authors:  D Ross-Degnan; S B Soumerai
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

9.  Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.

Authors:  Sebastian Schneeweiss; Stephen B Soumerai; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Alexander M Walker
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

10.  Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Authors:  Sebastian Schneeweiss; Alexander M Walker; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Stephen B Soumerai
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245
  10 in total
  1 in total

1.  Exchanging health lessons globally.

Authors:  Tessa Richards
Journal:  BMJ       Date:  2004-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.